Aaron Siri is interviewing and helping choose candidates for high-level health roles, according to the New York Times.

Aaron Siri - a lawyer with a history of seeking to expand exemptions to vaccines- asked the FDA to suspend or withdraw ...

Gilead CEO Daniel O’Day has hired Berger away from Sanofi. Elsewhere, Lonza is reorganizing and Bausch + Lomb is exploring a ...

Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Sanofi ( (SNY) ) has issued an announcement.

Reform UK looks set to win a Labour stronghold in London at the next general election in what would be a major blow to Sir ...

Sanofi SNY announced that the FDA has granted a Breakthrough Therapy designation to its investigational oral BTK inhibitor, ...

The FDA has granted Breakthrough Therapy designation to tolebrutinib for treating adults with non-relapsing secondary ...

Shares of Novavax rose nearly 1% after the open on Friday, continuing a positive streak with gains expected for the third ...

As the petition before the FDA notes, the current vaccine, manufactured by Sanofi, was not tested against a placebo; ...

REGN's lead drug, Eylea, faces a rapid decline in sales, which has impacted overall performance, even though Dupixent maintains momentum. We advise investors to wait and watch for now.

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to tolebrutinib for the treatment of ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...